Lynda Dee

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

Boris Jülg, Lynda Dee, Jintanat Ananworanich et al. · The Lancet HIV · 2019 · 206 citations

Pharmacy, Pharmacotherapy, Good Clinical Practice +12

“We Need to Deploy Them Very Thoughtfully and Carefully”: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States—A Qualitative Inquiry

Karine Dubé, David Evans, Lynda Dee et al. · AIDS Research and Human Retroviruses · 2017 · 70 citations · Full text

Public Health, Health Policy, Health Sciences +11

'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States

Karine Dubé, Jeff Taylor, Laurie Sylla et al. · PLoS ONE · 2017 · 66 citations · Full text

Public Health, Health Policy, Public Health Ethics +13

Perceptions of Equipoise, Risk–Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry

Karine Dubé, Lynda Dee, David Evans et al. · Journal of Empirical Research on Human Research Ethics · 2017 · 40 citations

Public Health, Health Policy, Public Health Ethics +11

Altruism: Scoping review of the literature and future directions for HIV cure-related research

Karine Dubé, Kelly E. Perry, Kushagra Mathur et al. · Journal of Virus Eradication · 2020 · 35 citations · Full text

Public Health, Pharmacotherapy, Hiv Control +7